MOSCOW, January 19
Advertisement
Russia’s consumer health watchdog Rospotrebnadzor on Tuesday said Russia’s second vaccine against Covid-19 is 100% effective based on the results of clinical trials, the TASS news agency reported.
Russia began mass trials of EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November. Moscow has said its other approved vaccine, Sputnik V, is 92% effective at protecting people from Covid according to interim results. — Reuters
Advertisement
×
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Combo
Yearly
Monthly
Already a Member? Sign In Now
Advertisement
Advertisement
Advertisement